CrUX Dataset

CrUX Top 50m

Greenhouse

Chief People Officer

Amanda Valentino

Chief Executive Officer

Axel Hoos

Chief Financial Officer

Brian Piper

Chief Scientific Officer

Darrin Stuart

Chief Development Officer

Guy Padbury

Chief Operating Officer

Kristin Schuhwerk

VP of Chemical Biology

Brent Martin

Vice President of Chemistry

Dave Jean

Executive Vice President, Target Biology

Erica Jackson

Vice President of Data Science

Gregory Kryukov

Paulina Hill

Shelley Chu

Albert Cha

Chelsea Place Johnson

Gaddy Getz

Founder

Chih-Chiang Tsou

Director, Head of Chemical Biology Informatics

Adam Friedman

President and CEO

Michael Streit

Chief Medical Officer

Keith Flaherty

Co-Founder & Board Member

Liron Bar-Peled

Biotechnology Late Stage Companies With More Than 10 Employees

United States Companies With Less Than $50M in Revenue (Top 10K)

Biotechnology Companies With Less Than $1B in Revenue (Top 10K)

East Coast Companies With Less Than $1B in Revenue (Top 10K)

Scorpion Therapeutics is a clinical-stage oncology company specializing in precision medicine for cancer patients. It develops targeted small-molecule drugs to interact with validated cancer targets. It aims to leverage its platform to advance a broad pipeline of wholly-owned, optimized compounds across molecules targeting validated oncogene targets, molecules for previously undruggable targets, and molecules for novel cancer targets.

Frazier Life Sciences

Lightspeed Venture Partners

Series C - Scorpion Therapeutics

Boxer Capital

EcoR1 Capital

Vida Ventures

Series B - Scorpion Therapeutics

Atlas Venture

Omega Funds

Series A - Scorpion Therapeutics

Computer and Software Services and Scientific Services

Boston

Massachusetts

United States

North America

Scorpion Therapeutics

Pierre Fabre Laboratories and Scorpion Therapeutics Annou...

Most-Active US Investors In July: Andreessen Horowitz Led Cool Month

Scorpion Therapeutics Inks $150 Million Series C

Scorpion Therapeutics Raises $150 Million For Enhancing Clinical-Stage Precision Oncology Pipeline

The Week’s 10 Biggest Funding Rounds: Cardurion Pharmaceuticals And Human Interest Nab Largest Raises

Scorpion Therapeutics secures $150m for oncology pipeline

Boston Therapeutics rakes in $150m Series C

Scorpion Therapeutics Announces $150 Million Series C Financing to Advance Leading Clinical-stage Precision Oncology Pipeline

Scorpion snaps up $150M in series C funds to widen clinical plans for cancer pipeline

Philippines

Asia

Mexico

India

Belgium

Europe

Scorpion Therapeutics is a biopharmaceutical company focused on developing the next generation of targeted cancer therapies. They aim to deliver superior precision medicines through the integration of advanced technologies and scientific excellence.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Nov 14, 2024 2:01 PM	e0b56ff7
public peers	general
news daily refresh	general	Sep 3, 2024 1:50 PM	18616965
news processing daily refresh	general	Sep 3, 2024 2:46 PM	a12ebec5
news impact assignment daily	general	Sep 3, 2024 2:47 PM	8096ed90
news processing basic	general	Nov 14, 2024 10:16 AM	642107e7
company summary	general	Aug 30, 2024 7:47 PM	ce22517c
signals	general
crunchbase trigger	general	Oct 28, 2024 1:50 PM	ccc077d5
crunchbase profile	general	Oct 28, 2024 1:56 PM	8dd2ee8f
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	616439ef
peers	general
news basic	general	Mar 8, 2024 10:37 AM	3d003127
bundesanzeiger	filings
financials download nd	financials
private financials	financials

SCOR

COM:SCORPIONTX

Scorpion Therapeutics